Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IPPK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PLIN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED26 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIF9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NTPCR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF4EBP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
UBAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TTC17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LSG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STAG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TCTN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NSUN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IPO9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SELK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GMEB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on